The Therapeutic Goods Administration (TGA) delayed an announcement on the down-scheduling of CBD until late-December to consider further advice from a joint meeting of the Advisory Committees on Medicines and Chemicals Scheduling, Cannabiz has been told.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The TGA said public consultation on the interim decision to down-schedule low-dose CBD was open from September 9 to October 13 and no further consultation will take place.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...